Literature DB >> 23293900

Ventral prefrontal executive function impairment as a potential endophenotypic marker for bipolar disorder.

Almila Erol1, Ferdi Kosger, Gulperi Putgul, Bilal Ersoy.   

Abstract

BACKGROUND: Patients with remitted bipolar disorder have cognitive impairments, particularly in executive functions. However, the findings of studies that investigated cognitive functions in unaffected relatives of patients with bipolar disorder are conflicting. AIMS: The aim of this study is to investigate executive functions in healthy parents of patients with bipolar I disorder, along with bipolar I disorder patients and matched controls. It has been hypothesized that both patients with bipolar I disorder and their parents would have executive function impairments compared with controls.
METHODS: 25 patients with bipolar I disorder, in full remission, 25 healthy controls that matched the patients with respect to age, gender and education, 50 healthy parents of those patients and 50 healthy controls that matched the parents for age, gender and education were included in the study. All the participants were interviewed with Structured Clinical Interview for DSM-IV-Axis I (SCID-I). Executive functions were assessed using the Verbal Fluency Test (VFT), Trail Making Test (TMT), Wisconsin Card Sorting Test (WCST) and Stroop Test.
RESULTS: Patients performed significantly worse than their matched controls on the VFT, TMT and Stroop tests, but not on the WCST. Parents performed significantly worse than their matched controls on the TMT and Stroop tests, but not on the VFT and WCST.
CONCLUSIONS: Our results bring more evidence that deficits in ventral, but not dorsal prefrontal executive functions are associated with familial vulnerability to bipolar disorder and ventral prefrontal executive function impairments may represent a potential endophenotype for bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23293900     DOI: 10.3109/08039488.2012.756062

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  7 in total

1.  Bipolar Patients with Vascular Risk Display a Steeper Age-Related Negative Slope in Inhibitory Performance but Not Processing Speed: A Preliminary Study.

Authors:  Sheena I Dev; Lisa T Eyler
Journal:  Am J Geriatr Psychiatry       Date:  2016-12-07       Impact factor: 4.105

2.  Early signs of anomalous neural functional connectivity in healthy offspring of parents with bipolar disorder.

Authors:  Manpreet K Singh; Kiki D Chang; Ryan G Kelley; Manish Saggar; Allan L Reiss; Ian H Gotlib
Journal:  Bipolar Disord       Date:  2014-06-17       Impact factor: 6.744

Review 3.  Neurocognitive functioning in euthymic patients with bipolar disorder and unaffected relatives: A review of the literature.

Authors:  Stephanie A Cardenas; Layla Kassem; Melissa A Brotman; Ellen Leibenluft; Francis J McMahon
Journal:  Neurosci Biobehav Rev       Date:  2016-08-05       Impact factor: 8.989

4.  Variants Near CCK Receptors are Associated With Electrophysiological Responses to Pre-pulse Startle Stimuli in a Mexican American Cohort.

Authors:  Trina M Norden-Krichmar; Ian R Gizer; Evelyn Phillips; Kirk C Wilhelmsen; Nicholas J Schork; Cindy L Ehlers
Journal:  Twin Res Hum Genet       Date:  2015-11-26       Impact factor: 1.587

Review 5.  Neurobiology of Risk for Bipolar Disorder.

Authors:  Ayşegül Özerdem; Deniz Ceylan; Güneş Can
Journal:  Curr Treat Options Psychiatry       Date:  2016-10-20

6.  Aberrant Functional Connectivity of Sensorimotor Network and Its Relationship With Executive Dysfunction in Bipolar Disorder Type I.

Authors:  Wenjing Zhu; Wenxin Tang; Yan Liang; Xiaoying Jiang; Yi Li; Zhiyu Chen; Cheng Zhu
Journal:  Front Neurosci       Date:  2022-02-21       Impact factor: 4.677

7.  Disturbances of Dynamic Function in Patients With Bipolar Disorder I and Its Relationship With Executive-Function Deficit.

Authors:  Yan Liang; Xiaoying Jiang; Wenjing Zhu; Yonghui Shen; Fengfeng Xue; Yi Li; Zhiyu Chen
Journal:  Front Psychiatry       Date:  2020-09-24       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.